Metformin in Head and Neck Squamous Cell Carcinoma: Effect on Tissue Oxygenation

NCT03510390 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer
Oral Cavity Squamous Cell Carcinoma

Interventions

DRUG: Metformin

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]